Although, there is a rationale for the use of TZDs in patients with type 2 diabetes mellitus and they have been seen to be very effective, clinical studies have produced conflicting data, and several important aspects of PPARγ action remain confusing and unresolved. Here, PPARG is linked to type 2 diabetes mellitus.